GENEVA, Oct. 1 -- AMPHISTA THERAPEUTICS LIMITED filed a patent application (EP2026/056752) for “COMBINATIONS COMPRISING Y116 OR CFT8634, AS BRD9 BIFUNCTIONAL COMPOUNDS, FOR USE IN THE TREATMENT OF CANCER”. With publication no. WO/2026/190172, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/499
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....